Showing results (2771-2780 of 4,783) with videos related to

Sort By:
Pageof 479
Drug Discovery Today|April 7, 2023
Role of SIRT3 in mitochondrial biology and its therapeutic implications in neurodegenerative disordersYogesh Mishra, Ravinder K Kaundal
Drug Discovery Today|March 30, 2021
Small-molecule modulators of the circadian clock: Pharmacological potentials in circadian-related diseasesRodrigo F N Ribeiro, Cláudia Cavadas, Maria Manuel C Silva
Drug Discovery Today|March 30, 2021
Long noncoding RNAs have pivotal roles in chemoresistance of acute myeloid leukemiaMehrdad Izadirad, Leila Jafari, Alva Rani James, et al.
Drug Discovery Today|April 6, 2015
Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agentsShao-Lin Zhang, Xiaohui Hu, Wen Zhang, et al.
Drug Discovery Today|February 21, 2015
Cruzain inhibitors: efforts made, current leads and a structural outlook of new hitsKarina Martinez-Mayorga, Kendall G Byler, Ariadna I Ramirez-Hernandez, et al.
Drug Discovery Today|August 9, 2020
Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance?Alessandro Dalpiaz, Guglielmo Paganetto, Giada Botti, et al.
Drug Discovery Today|April 1, 2023
Advances in receptor chromatography for drug discovery and drug-receptor interaction studiesJia Fu, Wei Qin, Lu-Qi Cao, et al.
Drug Discovery Today|April 2, 2023
Promise of dostarlimab in cancer therapy: Advancements and cross-talk considerationsQuratulain Babar, Ayesha Saeed, Sivasubramanian Murugappan, et al.
Drug Discovery Today|May 25, 2023
Challenges and advances in antimicrobial peptide developmentKamila Botelho Sampaio de Oliveira, Michel Lopes Leite, Victor Albuquerque Cunha, et al.
Drug Discovery Today|May 5, 2023
Virtual patients, digital twins and causal disease models: Paving the ground for in silico clinical trialsPhilippe Moingeon, Marylore Chenel, Cécile Rousseau, et al.
Pageof 479